Macy's, Inc.: Form 10-Q for the period ended Nov 1, 2025
Filed with the SEC on Dec 10, 2025 and accepted by EDGAR at Dec 10, 2025, 16:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-11-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-08-03 to 2025-11-01 | $4.71bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2025-02-02 to 2025-11-01 | $14.13bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-08-03 to 2025-11-01 | $2.85bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2025-02-02 to 2025-11-01 | $8.55bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2025-08-03 to 2025-11-01 | $2.02bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2025-02-02 to 2025-11-01 | $5.88bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-08-03 to 2025-11-01 | $42.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-02-02 to 2025-11-01 | $285.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-08-03 to 2025-11-01 | −$6.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-02-02 to 2025-11-01 | $52.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-08-03 to 2025-11-01 | $11.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-02-02 to 2025-11-01 | $135.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-08-03 to 2025-11-01 | $0.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-02-02 to 2025-11-01 | $0.48 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-08-03 to 2025-11-01 | $0.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-02-02 to 2025-11-01 | $0.50 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-08-03 to 2025-11-01 | 274,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-02-02 to 2025-11-01 | 277,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-02-02 to 2025-11-01 | $247.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-02-02 to 2025-11-01 | $272.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2025-02-02 to 2025-11-01 | $149.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2025-02-02 to 2025-11-01 | $200.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-11-01 | $447.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-11-01 | $7.38bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-11-01 | $17.06bn | us-gaap:Assets |
| Current liabilities | At period end2025-11-01 | $5.89bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2025-11-01 | $2.43bn | us-gaap:LongTermDebt |
| Current portion of debt | At period end2025-11-01 | $0 | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2025-11-01 | $4.33bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-25-056323. Last ingested by Listed: Oct 24, 2026, 14:57 ET. Listed shows no prices and gives no investment advice.